YOUR BUSINESS AUTHORITY
Springfield, MO
Pfizer Inc. is in talks to buy biotech firm Seagan Inc., people familiar with the matter told The Wall Street Journal.
The deal could be valued at more than $30 billion, the sources said.
The sources said the deal is in the early stages.
Read more from The Wall Street Journal.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach